P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. (23rd June 2022) - Wong, R.; Fishman, J.; Wilson, K.; Yeh, M.; Hakimi, Z.; Yee, C.; Huynh, L.; Duh, M. S.